Institute for Cardiovascular diseases Dedinje

Belgrade 11040

2 studies enrolling now · 11 studies all time

What they study most

Acute Coronary Syndrome, Acute Heart Failure With Reduced Ejection Fraction, Acute Myocardial Infarction, Atrial Fibrillation, Cardiovascular Risk, Chronic Kidney Disease, Coronary Artery Disease, Heart Failure, Inflammation, Myocardial Infarction, Non ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction

Studies at this site

• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• CRF2 Agonist for the Treatment of Worsening Heart Failure — Paused
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry — Completed
• A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction — Stopped early
• RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism — Completed